| UniProt ID | TWF2_HUMAN | |
|---|---|---|
| UniProt AC | Q6IBS0 | |
| Protein Name | Twinfilin-2 | |
| Gene Name | TWF2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 349 | |
| Subcellular Localization | Cytoplasm, cytoskeleton . Cytoplasm, perinuclear region . Cell projection, stereocilium. Perinuclear and G-actin-rich cortical actin structure sublocalization. | |
| Protein Description | Actin-binding protein involved in motile and morphological processes. Inhibits actin polymerization, likely by sequestering G-actin. By capping the barbed ends of filaments, it also regulates motility. Seems to play an important role in clathrin-mediated endocytosis and distribution of endocytic organelles. May play a role in regulating the mature length of the middle and short rows of stereocilia (By similarity).. | |
| Protein Sequence | MAHQTGIHATEELKEFFAKARAGSVRLIKVVIEDEQLVLGASQEPVGRWDQDYDRAVLPLLDAQQPCYLLYRLDSQNAQGFEWLFLAWSPDNSPVRLKMLYAATRATVKKEFGGGHIKDELFGTVKDDLSFAGYQKHLSSCAAPAPLTSAERELQQIRINEVKTEISVESKHQTLQGLAFPLQPEAQRALQQLKQKMVNYIQMKLDLERETIELVHTEPTDVAQLPSRVPRDAARYHFFLYKHTHEGDPLESVVFIYSMPGYKCSIKERMLYSSCKSRLLDSVEQDFHLEIAKKIEIGDGAELTAEFLYDEVHPKQHAFKQAFAKPKGPGGKRGHKRLIRGPGENGDDS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAHQTGIHA ------CCCCCCCCC | 11.96 | 19413330 | |
| 5 | Phosphorylation | ---MAHQTGIHATEE ---CCCCCCCCCCHH | 28.39 | 27050516 | |
| 14 | Acetylation | IHATEELKEFFAKAR CCCCHHHHHHHHHHH | 56.61 | 19608861 | |
| 19 | Acetylation | ELKEFFAKARAGSVR HHHHHHHHHHCCCEE | 32.99 | 19608861 | |
| 24 | Phosphorylation | FAKARAGSVRLIKVV HHHHHCCCEEEEEEE | 11.77 | 29514088 | |
| 98 | Acetylation | DNSPVRLKMLYAATR CCCHHHHHHHHHHHH | 19.12 | 25953088 | |
| 109 | Acetylation | AATRATVKKEFGGGH HHHHHHHHHHHCCCC | 42.08 | 12435391 | |
| 110 | Acetylation | ATRATVKKEFGGGHI HHHHHHHHHHCCCCC | 54.67 | 19825739 | |
| 110 | Malonylation | ATRATVKKEFGGGHI HHHHHHHHHHCCCCC | 54.67 | 26320211 | |
| 118 | Acetylation | EFGGGHIKDELFGTV HHCCCCCCCCHHEEC | 39.20 | 26822725 | |
| 136 | Ubiquitination | LSFAGYQKHLSSCAA CCCCCHHHHHHHCCC | 37.72 | 29967540 | |
| 136 | Acetylation | LSFAGYQKHLSSCAA CCCCCHHHHHHHCCC | 37.72 | 26051181 | |
| 139 | O-linked_Glycosylation | AGYQKHLSSCAAPAP CCHHHHHHHCCCCCC | 24.08 | 29351928 | |
| 139 | Phosphorylation | AGYQKHLSSCAAPAP CCHHHHHHHCCCCCC | 24.08 | 23312004 | |
| 140 | Phosphorylation | GYQKHLSSCAAPAPL CHHHHHHHCCCCCCC | 17.71 | 23312004 | |
| 141 | S-nitrosylation | YQKHLSSCAAPAPLT HHHHHHHCCCCCCCC | 3.17 | 2212679 | |
| 148 | Phosphorylation | CAAPAPLTSAERELQ CCCCCCCCHHHHHHH | 25.49 | 50558245 | |
| 149 | Phosphorylation | AAPAPLTSAERELQQ CCCCCCCHHHHHHHH | 35.50 | 25159151 | |
| 149 | O-linked_Glycosylation | AAPAPLTSAERELQQ CCCCCCCHHHHHHHH | 35.50 | 29351928 | |
| 163 | Sumoylation | QIRINEVKTEISVES HHHHCCCCCEEEECC | 33.97 | - | |
| 163 | Sumoylation | QIRINEVKTEISVES HHHHCCCCCEEEECC | 33.97 | - | |
| 167 | Phosphorylation | NEVKTEISVESKHQT CCCCCEEEECCCCCC | 17.38 | 101544677 | |
| 171 | Ubiquitination | TEISVESKHQTLQGL CEEEECCCCCCHHHH | 26.65 | 29967540 | |
| 174 | Phosphorylation | SVESKHQTLQGLAFP EECCCCCCHHHHHCC | 22.29 | 28555341 | |
| 194 | Acetylation | QRALQQLKQKMVNYI HHHHHHHHHHHHHHH | 43.46 | 25953088 | |
| 194 | Ubiquitination | QRALQQLKQKMVNYI HHHHHHHHHHHHHHH | 43.46 | 29967540 | |
| 196 | Acetylation | ALQQLKQKMVNYIQM HHHHHHHHHHHHHHH | 43.14 | 25953088 | |
| 200 | Phosphorylation | LKQKMVNYIQMKLDL HHHHHHHHHHHHHHH | 4.90 | 25072903 | |
| 276 | Ubiquitination | RMLYSSCKSRLLDSV HHHHHHHHHHHHHHH | 40.33 | 24816145 | |
| 304 | Phosphorylation | IGDGAELTAEFLYDE ECCCCEEEEHHHHCC | 18.69 | 28060719 | |
| 309 | Phosphorylation | ELTAEFLYDEVHPKQ EEEEHHHHCCCCHHH | 18.51 | 27273156 | |
| 315 | Ubiquitination | LYDEVHPKQHAFKQA HHCCCCHHHHHHHHH | 39.58 | 29967540 | |
| 320 | Ubiquitination | HPKQHAFKQAFAKPK CHHHHHHHHHHCCCC | 41.31 | 29967540 | |
| 325 | Ubiquitination | AFKQAFAKPKGPGGK HHHHHHCCCCCCCCC | 40.59 | 27667366 | |
| 325 | Acetylation | AFKQAFAKPKGPGGK HHHHHHCCCCCCCCC | 40.59 | 25953088 | |
| 340 | Methylation | RGHKRLIRGPGENGD CCCCCCCCCCCCCCC | 50.25 | - | |
| 349 | Phosphorylation | PGENGDDS------- CCCCCCCC------- | 47.03 | 26846344 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TWF2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TWF2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TWF2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-14 AND LYS-19, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-309 AND SER-349, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-349, AND MASSSPECTROMETRY. | |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-309, AND MASSSPECTROMETRY. | |